A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest NewsOver 500 Clients, Large & Small from Around the World, Have Trusted Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 341
Comprehensive Pages
- 34
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
2023 IOL Market Report: Global Analysis for 2022 to 2028, April, 2023
The “2023 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs. Additionally, 34 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
11/22/2023
BreakingLaserRevenueSurgical
Q3-2023 Ophthalmic Revenue Roundup for Alcon, Iridex, and Lensar
Alcon reported Nov. 14 that its Q3-2023 net sales totaled $2.3 billion, an 8 percent increase (+9 percent cc) over $2.1 billion in Q3-2022. Surgical net sales for implantables, consumables, and equ...
11/22/2023
BreakingEuropeGlaucomaPharmaRegulation
Santen Receives EU Approval for Catiolanze (Preservative-Free Latanoprost) in Glaucoma
Japanese drugmaker Santen Pharmaceutical announced Nov. 17 that the European Commission had approved its marketing authorization application for preservative-free Catiolanze (cationic emulsion of l...
11/21/2023
AAOMeetingNewsletterRetina
Retina Specialists Face Complement Inhibition Therapy with Mixed Emotions
The use of complement inhibitors to slow the progression of geographic atrophy (GA) is shaping up as the fulcrum for changing how ophthalmologists deliver and get compensated for retina care. Two c...
11/22/2023
BreakingDry EyeRegulation
Amazon Removes Seven Eye Drop Products After FDA Warning
Online retailer Amazon has removed seven eye drop products from its site after the US FDA warned the company that the products were unapproved drugs, making claims to relieve conjunctivitis or floa...
11/22/2023
BreakingClinical TrialIndustryRetina
Oxurion to File for Bankruptcy After DME Candidate Misses Phase II Endpoint
Belgium’s Oxurion reported Nov. 20 that it would take the steps necessary to file for bankruptcy after its plasma kallikrein inhibitor THR-149 failed to reach its primary endpoint of improvement in...
11/22/2023
BreakingDealsDiagnostic
Keeler and Long Grove Pharmaceuticals Enter Agreement for Distribution of Ak-fluor
Ophthalmic company Keeler announced Nov. 15 that it had formed a partnership with Long Grove Pharmaceuticals to distribute Ak-fluor (fluorescein injection) for diagnostic fluorescein angiography. L...
11/21/2023
AAOCataractMeetingNewsletterSurgical
Pros and Cons of Same-Day Cataract Surgery Debated During AAO Refractive Day
The advantages and disadvantages of immediate sequential bilateral cataract surgery (ISBCS) took center stage during a 2023 AAO Refractive Day session that tasked Rupert Menapace, MD (Austria), wit...
11/21/2023
AAOMeetingMyopiaNewsletterRefractiveSurgical
US Refractive Surgeons Grapple with Treatment Options for High Myopes
Surgeons attending the Refractive Subspecialty Day at the 2023 AAO meeting in San Francisco debated the ideal treatment options for patients with moderate to high myopia. Practices shared widely di...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.